Official Publications argenx SE

Equities

Real-time Euronext Bruxelles Other stock markets 06:31:48 2024-04-24 am EDT			5-day change	1st Jan Change
354.7 ^EUR	+1.58%		+4.32%	+3.26%

Apr. 17	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
Apr. 16	Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy	CI

Mixed general shareholder meeting	Mar. 25	CO
SEC Filing 20 F	Mar. 20	CO
Annual ESG Report	Mar. 20	CO
Annual Report	Mar. 20	CO
SEC Filing 13G	Feb. 28	CO
SEC Filing 6K-4	Feb. 28	CO
Slide show results	Feb. 28	CO
Annual results	Feb. 28	CO
Threshold crossings	Jan. 31	CO
Threshold crossings	Jan. 30	CO
Threshold crossings	Jan. 25	CO
Admission of new securities	Dec. 30	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	Dec. 18	CO
Threshold crossings	Oct. 31	CO
Slide show Q3	23-10-30	CO
3rd quarter results	23-10-30	CO
SEC Filing 6K-3	23-10-30	CO
Threshold crossings	23-10-19	CO
Admission of new securities	23-09-29	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-19	CO
Threshold crossings	23-09-18	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-14	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-11	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-07	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-08-30	CO